3-chloro-1-ethylquinoxalin-2(1H)-one | 869199-17-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 3-chloro-1-ethylquinoxalin-2(1H)-one
• 英文别名: 3-chloro-1-ethyl-1H-quinoxalin-2-one；3-Chloro-1-ethyl-1,2-dihydroquinoxalin-2-one；3-chloro-1-ethylquinoxalin-2-one
• CAS: 869199-17-7
• 化学式: C₁₀H₉ClN₂O
• mdl: MFCD29762729
• 分子量: 208.647
• InChiKey: IXOBNBZVJNXHJF-UHFFFAOYSA-N

物化性质

• 沸点：
  332.7±25.0 °C(Predicted)
• 密度：
  1.32±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  32.7
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-chloro-1-ethylquinoxalin-2(1H)-one 、 4-氨基-N-噻吩-2-甲基苯甲酰胺 以 乙腈 为溶剂， 生成 4-(4-ethyl-3-oxo-3,4-dihydro-quinoxalin-2-ylamino)-N-thiophen-2-ylmethyl-benzamide
  参考文献：
  名称：

  Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors

  摘要：

  A series of 3-anilino-quinoxalinones has been identified as a new class of glycogen phosphorylase inhibitors. The lead compound I was identified through high throughput screening as well as through pharmacophore-based electronic screening. Modifications were made to the scaffold of 1 to produce novel analogues, some of which are 25 times more potent than the lead compound. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.07.021
• 作为产物：
  描述：

  1-乙基-2(1H)-喹喔啉酮 在 aluminum (III) chloride 、 氯仿 、 [Ir(dF(CF₃)-ppy)₂(4,4'dCF₃-bpy)]PF₆ 作用下， 以77 %的产率得到3-chloro-1-ethylquinoxalin-2(1H)-one
  参考文献：
  名称：

  使用 CHCl3 作为氯源实现的 quinoxalin-2(1H)-ones 的光氧化还原催化氯化

  摘要：

  使用 CHCl 3作为氯源，开发了一种光氧化还原催化的 quinoxalin-2(1 H )-ones 氯化反应，从而以中等至高产率提供了各种 3-chloroquinoxalin-2(1 H )-ones。该方案的特点是反应条件温和、区域选择性好、氯化剂易得。考虑到这种氯化方法的操作简单性和低成本，这种开发的方法为将氯官能团快速结合到杂芳烃中提供了一种创新途径，并将激发更广泛地开发新的氯化策略。

  DOI：

  10.1039/d2cc04520f

文献信息

• Quinoxalinones
  申请人：Beavers Pat Mary

  公开号：US20050148586A1

  公开（公告）日：2005-07-07

  The invention features quinoxalinones, pharmaceutical compositions containing them and methods of using them to treat, for example, diabetes.

  这项发明涉及喹喔啉酮，包含它们的药物组合物以及使用它们治疗糖尿病等疾病的方法。
• (3-OXO-3,4-DIHYDRO-QUINOXALIN-2-YL-AMINO)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS GLYCOGEN PHOSPHORYLASE INHIBITORS FOR THE TREATMENT OF DIABETES AND OBESITY
  申请人：JANSSEN PHARMACEUTICA N.V.

  公开号：EP1711184A1

  公开（公告）日：2006-10-18
• [EN] (3-OXO-3, 4-DIHYDRO-QUINOXALIN-2-YL-AMINO) -BENZAMIDE DERIVATIVES AND RELATED COMPOUND AS GLYCOGEN PHOSPHORYLASE INHIBITORS FOR THE TREATMENT OF DIABETES AND OBESITY<br/>[FR] DERIVES DE (3-OXO-3, 4-DIHYDRO-QUINOXALIN-2-YL-AMINO)-BENZAMIDE ET COMPOSES AFFERENTS COMME INHIBITEURS DE LA GLYCOGENE PHOSPHORYLASE DANS LE TRAITEMENT DU DIABETE ET DE L'OBESITE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2005067932A1

  公开（公告）日：2005-07-28

  The invention features pharmaceutically active quinoxalinones of formula (1), compositions containing them, and methods of making and using theme: Formula (I) wherein R1 is H, C 1-6 alkyl, or halo; R2 is H or halo; R3 is H, C 1-6 alkyl, X is N or CH; Y is a covalent bond, -NHCO- or -CONH-; Z is phenyl or a 5 or 6-membered heterocyclyl with between l and 2 heteroatoms independently selected from N, O, and S; and n is 0, 1 or 2; or a pharmaceutically acceptable salt, ester, amide, hydrate, or solvate thereof; as well as their use as glycogen phosphorylase inhibitors for the treatment of i diabetes and obesity.